This paper presents a lightweight framework for classifying brain stroke types from Diffusion-Weighted Imaging (DWI) MRI scans, employing a Multi-Layer Perceptron (MLP) neural network with Wavelet Transform for feature extraction. Accurate and timely stroke detection is critical for effective treatment and improved patient outcomes in neuroimaging. While Convolutional Neural Networks (CNNs) are widely used for medical image analysis, their computational complexity often hinders deployment in resource-constrained clinical settings. In contrast, our approach combines Wavelet Transform with a compact MLP to achieve efficient and accurate stroke classification. Using the "Brain Stroke MRI Images" dataset, our method yields classification accuracies of 82.0% with the "db4" wavelet (level 3 decomposition) and 86.00% with the "Haar" wavelet (level 2 decomposition). This analysis highlights a balance between diagnostic accuracy and computational efficiency, offering a practical solution for automated stroke diagnosis. Future research will focus on enhancing model robustness and integrating additional MRI modalities for comprehensive stroke assessment.

Multimodal medical image fusion (MMIF) extracts the most meaningful information from multiple source images, enabling a more comprehensive and accurate diagnosis. Achieving high-quality fusion results requires a careful balance of brightness, color, contrast, and detail; this ensures that the fused images effectively display relevant anatomical structures and reflect the functional status of the tissues. However, existing MMIF methods have limited capacity to capture detailed features during conventional training and suffer from insufficient cross-modal feature interaction, leading to suboptimal fused image quality. To address these issues, this study proposes a two-stage diffusion model-based fusion network (DM-FNet) to achieve unified MMIF. In Stage I, a diffusion process trains UNet for image reconstruction. UNet captures detailed information through progressive denoising and represents multilevel data, providing a rich set of feature representations for the subsequent fusion network. In Stage II, noisy images at various steps are input into the fusion network to enhance the model's feature recognition capability. Three key fusion modules are also integrated to process medical images from different modalities adaptively. Ultimately, the robust network structure and a hybrid loss function are integrated to harmonize the fused image's brightness, color, contrast, and detail, enhancing its quality and information density. The experimental results across various medical image types demonstrate that the proposed method performs exceptionally well regarding objective evaluation metrics. The fused image preserves appropriate brightness, a comprehensive distribution of radioactive tracers, rich textures, and clear edges. The code is available at https://github.com/HeDan-11/DM-FNet.

Multi-parametric magnetic resonance imaging (mpMRI) exams have various series types acquired with different imaging protocols. The DICOM headers of these series often have incorrect information due to the sheer diversity of protocols and occasional technologist errors. To address this, we present a deep learning-based classification model to classify 8 different body mpMRI series types so that radiologists read the exams efficiently. Using mpMRI data from various institutions, multiple deep learning-based classifiers of ResNet, EfficientNet, and DenseNet are trained to classify 8 different MRI series, and their performance is compared. Then, the best-performing classifier is identified, and its classification capability under the setting of different training data quantities is studied. Also, the model is evaluated on the out-of-training-distribution datasets. Moreover, the model is trained using mpMRI exams obtained from different scanners in two training strategies, and its performance is tested. Experimental results show that the DenseNet-121 model achieves the highest F1-score and accuracy of 0.966 and 0.972 over the other classification models with p-value$<$0.05. The model shows greater than 0.95 accuracy when trained with over 729 studies of the training data, whose performance improves as the training data quantities grew larger. On the external data with the DLDS and CPTAC-UCEC datasets, the model yields 0.872 and 0.810 accuracy for each. These results indicate that in both the internal and external datasets, the DenseNet-121 model attains high accuracy for the task of classifying 8 body MRI series types.

Recent advancements in diffusion probabilistic models (DPMs) have revolutionized image processing, demonstrating significant potential in medical applications. Accurate segmentation of the left ventricle (LV) in echocardiograms is crucial for diagnostic procedures and necessary treatments. However, ultrasound images are notoriously noisy with low contrast and ambiguous LV boundaries, thereby complicating the segmentation process. To address these challenges, this paper introduces Echo-DND, a novel dual-noise diffusion model specifically designed for this task. Echo-DND leverages a unique combination of Gaussian and Bernoulli noises. It also incorporates a multi-scale fusion conditioning module to improve segmentation precision. Furthermore, it utilizes spatial coherence calibration to maintain spatial integrity in segmentation masks. The model's performance was rigorously validated on the CAMUS and EchoNet-Dynamic datasets. Extensive evaluations demonstrate that the proposed framework outperforms existing SOTA models. It achieves high Dice scores of 0.962 and 0.939 on these datasets, respectively. The proposed Echo-DND model establishes a new standard in echocardiogram segmentation, and its architecture holds promise for broader applicability in other medical imaging tasks, potentially improving diagnostic accuracy across various medical domains. Project page: https://abdur75648.github.io/Echo-DND

Lung cancer remains the leading cause of cancer-related mortality worldwide, due to lacking effective early-stage screening approaches. Imaging, such as low-dose CT, poses radiation risk, and biopsies can induce some complications. Additionally, traditional serum tumor markers lack diagnostic specificity. This highlights the urgent need for precise and non-invasive early detection techniques. This systematic review aims to evaluate the limitations of conventional screening methods (imaging/biopsy/tumor markers), seek breakthroughs in liquid biopsy for early lung cancer detection, and assess the potential value of Artificial Intelligence (AI), thereby providing evidence-based insights for establishing an optimal screening framework. We systematically searched the PubMed database for the literature published up to May 2025. Key words include "Artificial Intelligence", "Early Lung cancer screening", "Imaging examination", "Innovative technologies", "Liquid biopsy", and "Puncture biopsy". Our inclusion criteria focused on studies about traditional and innovative screening methods, with an emphasis on original research concerning diagnostic performance or high-quality reviews. This approach helps identify critical studies in early lung cancer screening. Novel liquid biopsy techniques are non-invasive and have superior diagnostic efficacy. AI-assisted diagnostics further enhance accuracy. We propose three development directions: establishing risk-based liquid biopsy screening protocols, developing a stepwise "imaging-AI-liquid biopsy" diagnostic workflow, and creating standardized biomarker panel testing solutions. Integrating traditional methodologies, novel liquid biopsies, and AI to establish a comprehensive early lung cancer screening model is important. These innovative strategies aim to significantly increase early detection rates, substantially enhancing lung cancer control. This review provides both theoretical guidance for clinical practice and future research.

Brain tumor classification using Magnetic Resonance Imaging (MRI) images is an important and emerging field of medical imaging and artificial intelligence in the current world. With advancements in technology, particularly in deep learning and machine learning, researchers and clinicians are leveraging these tools to create complex models that, using MRI data, can reliably detect and classify tumors in the brain. However, it has a number of drawbacks, including the intricacy of tumor types and grades, intensity variations in MRI data and tumors varying in severity. This paper proposes a Multi-Grade Hierarchical Classification Network Model (MGHCN) for the hierarchical classification of tumor grades in MRI images. The model's distinctive feature lies in its ability to categorize tumors into multiple grades, thereby capturing the hierarchical nature of tumor severity. To address variations in intensity levels across different MRI samples, an Improved Adaptive Intensity Normalization (IAIN) pre-processing step is employed. This step standardizes intensity values, effectively mitigating the impact of intensity variations and ensuring more consistent analyses. The model renders utilization of the Dual Tree Complex Wavelet Transform with Enhanced Trigonometric Features (DTCWT-ETF) for efficient feature extraction. DTCWT-ETF captures both spatial and frequency characteristics, allowing the model to distinguish between different tumor types more effectively. In the classification stage, the framework introduces the Adaptive Hierarchical Optimized Horse Herd BiLSTM Fusion Network (AHOHH-BiLSTM). This multi-grade classification model is designed with a comprehensive architecture, including distinct layers that enhance the learning process and adaptively refine parameters. The purpose of this study is to improve the precision of distinguishing different grades of tumors in MRI images. To evaluate the proposed MGHCN framework, a set of evaluation metrics is incorporated which includes precision, recall, and the F1-score. The structure employs BraTS Challenge 2021, Br35H, and BraTS Challenge 2023 datasets, a significant combination that ensures comprehensive training and evaluation. The MGHCN framework aims to enhance brain tumor classification in MRI images by utilizing these datasets along with a comprehensive set of evaluation metrics, providing a more thorough and sophisticated understanding of its capabilities and performance.

To assess the methodological quality of radiomics-based studies on bone chondrosarcoma using METhodological RadiomICs Score (METRICS) and Radiomics Quality Score (RQS). A literature search was conducted on EMBASE and PubMed databases for research papers published up to July 2024 and focused on radiomics in bone chondrosarcoma, with no restrictions regarding the study aim. Three readers independently evaluated the study quality using METRICS and RQS. Baseline study characteristics were extracted. Inter-reader reliability was calculated using intraclass correlation coefficient (ICC). Out of 68 identified papers, 18 were finally included in the analysis. Radiomics research was aimed at lesion classification (n = 15), outcome prediction (n = 2) or both (n = 1). Study design was retrospective in all papers. Most studies employed MRI (n = 12), CT (n = 3) or both (n = 1). METRICS and RQS adherence rates ranged between 37.3-94.8% and 2.8-44.4%, respectively. Excellent inter-reader reliability was found for both METRICS (ICC = 0.961) and RQS (ICC = 0.975). Among the limitations of the evaluated studies, the absence of prospective studies and deep learning-based analyses was highlighted, along with the limited adherence to radiomics guidelines, use of external testing datasets and open science data. METRICS and RQS are reproducible quality assessment tools, with the former showing higher adherence rates in studies on chondrosarcoma. METRICS is better suited for assessing papers with retrospective design, which is often chosen in musculoskeletal oncology due to the low prevalence of bone sarcomas. Employing quality scoring systems should be promoted in radiomics-based studies to improve methodological quality and facilitate clinical translation. Employing reproducible quality scoring systems, especially METRICS (which shows higher adherence rates than RQS and is better suited for assessing retrospective investigations), is highly recommended to design radiomics-based studies on chondrosarcoma, improve methodological quality and facilitate clinical translation. The low scientific and reporting quality of radiomics studies on chondrosarcoma is the main reason preventing clinical translation. Quality appraisal using METRICS and RQS showed 37.3-94.8% and 2.8-44.4% adherence rates, respectively. Room for improvement was noted in study design, deep learning methods, external testing and open science. Employing reproducible quality scoring systems is recommended to design radiomics studies on bone chondrosarcoma and facilitate clinical translation.

Deep learning (DL) models have shown promise in predicting axillary lymph node (ALN) status. However, most existing DL models were classification-only models and did not consider the practical application scenarios of multi-view joint prediction. Here, we propose a Multi-Task Learning (MTL) and Multi-Instance Learning (MIL) framework that simulates the real-world clinical diagnostic scenario for ALN status prediction in breast cancer. Ultrasound images of the primary tumor and ALN (if available) regions were collected, each annotated with a segmentation label. The model was trained on a training cohort and tested on both internal and external test cohorts. The proposed two-stage DL framework using one of the Transformer models, Segformer, as the network backbone, exhibits the top-performing model. It achieved an AUC of 0.832, a sensitivity of 0.815, and a specificity of 0.854 in the internal test cohort. In the external cohort, this model attained an AUC of 0.918, a sensitivity of 0.851 and a specificity of 0.957. The Class Activation Mapping method demonstrated that the DL model correctly identified the characteristic areas of metastasis within the primary tumor and ALN regions. This framework may serve as an effective second reader to assist clinicians in ALN status assessment.

Prostate cancer (PCa) is one of the most common types of cancer, seriously affecting adult male health. Accurate and automated PCa segmentation is essential for radiologists to confirm the location of cancer, evaluate its severity, and design appropriate treatments. This paper presents PCaSAM, a fully automated PCa segmentation model that allows us to input multi-modal MRI images into the foundation model to improve performance significantly. We collected multi-center datasets to conduct a comprehensive evaluation. The results showed that PCaSAM outperforms the generalist medical foundation model and the other representative segmentation models, with the average DSC of 0.721 and 0.706 in the internal and external datasets, respectively. Furthermore, with the assistance of segmentation, the PI-RADS scoring of PCa lesions was improved significantly, leading to a substantial increase in average AUC by 8.3-8.9% on two external datasets. Besides, PCaSAM achieved superior efficiency, making it highly suitable for real-world deployment scenarios.

Despite advances in endovascular stroke therapy (EST) devices and techniques, many patients are left with substantial disability, even if the final infarct volumes (FIVs) remain small. Here, we evaluate the performance of a machine learning (ML) approach using pre-treatment CT angiography (CTA) to identify this cohort of patients that may benefit from additional interventions. We identified consecutive large vessel occlusion (LVO) acute ischemic stroke (AIS) subjects who underwent EST with successful reperfusion in a multicenter prospective registry cohort. We included only subjects with FIV<30mL and recorded 90-day outcome (modified Rankin scale, mRS). A deep learning model was pre-trained and then fine-tuned to predict 90-day mRS 0-2 using pre-treatment CTA images (DSN-CTA model). The primary outcome was the predictive performance of the DSNCTA model compared to a logistic regression model with clinical variables, measured by the area under the receiver operating characteristic curve (AUROC). The DSN-CTA model was pre-trained on 1,542 subjects and then fine-tuned and cross-validated with 48 subjects, all of whom underwent EST with TICI 2b-3 reperfusion. Of this cohort, 56.2% of subjects had 90-day mRS 3-6 despite successful EST and FIV<30mL. The DSN-CTA model showed significantly better performance than a model with clinical variables alone when predicting good 90-day mRS (AUROC 0.81 vs 0.492, p=0.006). The CTA-based machine learning model was able to more reliably predict unexpected poor functional outcome after successful EST and small FIV for patients with LVO AIS compared to standard clinical variables. ML models may identify <i>a priori</i> patients in whom EST-based LVO reperfusion alone is insufficient to improve clinical outcomes. AIS＝ acute ischemic stroke; AUROC＝ area under the receiver operating characteristic curve; DSN-CTA＝ DeepSymNet-v3 model; EST＝ endovascular stroke therapy; FIV＝ final infarct volume; LVO＝ large vessel occlusion; ML＝ machine learning.